1-3 of 3
Kandace Gollomp
Close
Sort by
Journal Articles

Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients

Matthew R. Schuelke, Hamid Bassiri, Edward M. Behrens, Scott Canna, Colleen Croy, Amanda DiNofia, Kandace Gollomp, Stephan Grupp, Michele Lambert, Arathi Lambrix, Shannon L. Maude, Regina Myers, Haley Newman, Whitney Petrosa, Alix Seif, Kathleen E. Sullivan, David T. Teachey, Caroline Diorio
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5603–5607.
https://doi.org/10.1182/bloodadvances.2023010712
Published: 2023
Includes: Supplemental data
Journal Articles

Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations

Clinical Trials & Observations
Caroline Diorio, Kevin O. McNerney, Michele Lambert, Michele Paessler, Elizabeth M. Anderson, Sarah E. Henrickson, Julie Chase, Emily J. Liebling, Chakkapong Burudpakdee, Jessica H. Lee, Frances B. Balamuth, Allison M. Blatz, Kathleen Chiotos, Julie C. Fitzgerald, Therese M. Giglia, Kandace Gollomp, Audrey R. Odom John, Cristina Jasen, Tomas Leng, Whitney Petrosa, Laura A. Vella, Char Witmer, Kathleen E. Sullivan, Benjamin L. Laskin, Scott E. Hensley, Hamid Bassiri, Edward M. Behrens, David T. Teachey
Journal: Blood Advances
Blood Adv (2020) 4 (23): 6051–6063.
https://doi.org/10.1182/bloodadvances.2020003471
Published: 2020
Includes: Supplemental data
Journal Articles

ICAM-1–targeted thrombomodulin mitigates tissue factor–driven inflammatory thrombosis in a human endothelialized microfluidic model

Colin F. Greineder, Ian H. Johnston, Carlos H. Villa, Kandace Gollomp, Charles T. Esmon, Douglas B. Cines, Mortimer Poncz, Vladimir R. Muzykantov
Journal: Blood Advances
Blood Adv (2017) 1 (18): 1452–1465.
https://doi.org/10.1182/bloodadvances.2017007229
Published: 2017
Includes: Multimedia, Supplemental data